Improving access to diabetes medications by addressing cost-related barriers for providers
Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetes
This study is looking at ways to help doctors and healthcare providers better support people with type 2 diabetes who struggle to afford their medications, so they can get the treatments they need to stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10773079 on NIH RePORTER |
What this research studies
This research focuses on developing an intervention aimed at healthcare providers to help them navigate and address cost-related barriers that prevent patients with type 2 diabetes from accessing necessary glucose-lowering medications. It examines how high out-of-pocket costs and insurance restrictions impact the initiation and adherence to these medications, particularly newer therapies that can reduce cardiovascular risks. By understanding these challenges, the project aims to create strategies that enhance medication use and ultimately improve patient health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with type 2 diabetes who face challenges in accessing their prescribed medications due to cost-related restrictions.
Not a fit: Patients who do not have type 2 diabetes or those whose medication access is not affected by cost-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better access to essential diabetes medications, improving health outcomes for patients with type 2 diabetes.
How similar studies have performed: Other research has shown that addressing cost-related barriers can improve medication adherence and health outcomes, indicating that this approach has potential for success.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Luo, Jing — University of Pittsburgh at Pittsburgh
- Study coordinator: Luo, Jing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.